声辐射力脉冲弹性成像(ARFI)与其他无创方法在慢性HCV患者肝纤维化分期中的诊断准确性比较:单中心经验
单中心前瞻性研究纳入2103例慢性HCV患者,以瞬时弹性成像(TE)为参考标准,评估ARFI弹性成像对肝纤维化分期的诊断效能,并与FIB-4和APRI比较。ARFI诊断≥F2、≥F3和F4的最佳截断值分别为1.36 m/s、1.45 m/s和1.7 m/s,AUROC分别为0.89、0.94和0.95;ALT正常者截断值低于ALT升高者。结论认为ARFI是可靠的无创分期方法,诊断效能与FIB-4和APRI相当。
要点
- ARFI诊断≥F2、≥F3和F4的AUROC分别为0.89、0.94和0.95,以TE为参考标准。
- ARFI最佳截断值:≥F2为1.36 m/s,≥F3为1.45 m/s,F4为1.7 m/s。
- ALT正常者ARFI截断值低于ALT 1.1-<3 ULN者和ALT≥3 ULN者。
核心结论
- ARFI弹性成像是以TE为参考标准时可靠的无创肝纤维化分期方法,对显著纤维化和肝硬化的诊断效能与FIB-4和APRI评分相当。
研究设计与样本
- 单中心前瞻性研究,纳入2103例慢性HCV患者,以TE为参考标准,评估ARFI弹性成像诊断效能,并计算FIB-4和APRI。
诊断标准与关键数值
- ARFI诊断≥F2的最佳截断值为1.36 m/s,AUROC为0.89。
- ARFI诊断≥F3的最佳截断值为1.45 m/s,AUROC为0.94。
- ARFI诊断F4的最佳截断值为1.7 m/s,AUROC为0.95。
- ALT正常者、ALT 1.1-<3 ULN者和ALT≥3 ULN者的ARFI截断值分别为:F≥2为1.35 m/s、1.39 m/s、1.54 m/s;F3为1.44 m/s、1.58 m/s、1.6 m/s;F4为1.69 m/s、1.84 m/s、1.86 m/s。
- FIB-4预测显著纤维化和肝硬化的AUC为0.82-0.86,APRI为0.78-0.82,低于ARFI的0.89-0.95。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the reliability of ARFI elastography for liver fibrosis staging and compare it to other non-invasive assessment of hepatic fibrosis (FIB-4 and APRI) in chronic HCV (CHC) patients.
METHODS: A single-center, prospective study included 2103 CHC patients. Liver stiffness (LS) was evaluated by TE and ARFI elastography. FIB-4 and APRI were calculated. The area under the receiver-operating characteristic curve (AUROCs) was used to assess the diagnostic performance of ARFI elastography for staging of liver fibrosis using TE as a reference standard.
RESULTS: The best cut off values of ARFI elastography for diagnosis of ≥ F2, ≥ F3and F4 were 1.36 m/s, 1.45 m/s, and 1.7 m/s with AUROCs of 0.89, 0.94 and 0.95, respectively. ARFI elastography cut offs are lower in patients with normal ALT level compared to those with ALT level (1.1-< 3 ULN) and those with ALT level ≥ 3ULN (1.35 m/s vs 1.39 m/s vs 1.54 for F ≥ 2, 1.44 m/s vs 1.58 m/s vs 1.6 m/s for F3, 1.69 m/s, 1.84 m/s, 1.86 m/s for F4). FIB-4 (0.82-0.86) and APRI (0.78-0.82) yielded lower AUC in prediction of significant fibrosis and cirrhosis than ARFI elastography (0.89-0.95).
CONCLUSION: ARFI elastography is a reliable method for non-invasive staging of liver fibrosis in CHC patients when compared to TE with a good diagnostic performance comparable to FIB-4 and APRI scores for the prediction of significant fibrosis and cirrhosis.
引用
- Alem SA, Abdellatif Z, Mabrouk M, et al. Diagnostic accuracy of acoustic radiation force impulse elastography (ARFI) in comparison to other non-invasive modalities in staging of liver fibrosis in chronic HCV patients: single-center experience. Abdom Radiol (NY). 2019. PMID: 31028432. doi:10.1007/s00261-019-02031-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。